Tyrosine kinase inhibitors to treat liver cancer.

  title={Tyrosine kinase inhibitors to treat liver cancer.},
  author={Hung Quoc Huynh},
  journal={Expert opinion on emerging drugs},
  volume={15 1},
IMPORTANCE OF THE FIELD Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Although patients with early-stage disease have a good prognosis, there has been no effective therapy available for those with advanced disease. Despite the death risk of patients with advanced HCC being reduced with sorafenib therapy, many patients eventually turn out to be refractory to this therapy. Thus, treatment of HCC remains an urgent health concern. AREAS COVERED… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…